Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record is displayed with study details, eligibility criteria, locations, outcomes, and documents in place of a 403 error response.
    Difference
    75%
    Check dated 2026-11-10T19:09:15.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T19:28:07.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition to using “Super Intelligence” in place of “Artificial Intelligence.” The site revision label also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:43:34.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:13:57.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-block screen. Users are unable to view trial details, locations, or related information on this page.
    Difference
    20%
    Check dated 2026-09-22T23:06:33.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.6 to v3.7.0, indicating a newer version of the page system. This appears to be a minor update to the page template or backend rather than a modification to study content or details.
    Difference
    0.0%
    Check dated 2026-09-15T21:46:51.000Z thumbnail image

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.